Dibotermin alfa

N/A

Report date: 2022/03/17 13:44:44

Base Information

Drug NameDibotermin alfa
Drug Alias Name迪奥特明αdiboterminum alfadibotermine alfa地波特明αDibotermin alpha +[10] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionOsteogenesis stimulantsBone morphogenetic protein receptor type-2 modulatorsBone morphogenetic protein receptor type-1A modulators
TargetsBone morphogenetic protein receptor type-2Bone morphogenetic protein receptor type-1A
Therapy Area/IndicationsTibial FracturesFractures, BoneRadius Fractures +[6] 
Global Approved IndicationsTibial Fractures
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2002/09/09
Country/TerritoryCanadaUnited StatesSweden +[23] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMedtronic
China Registration ClassN/A

Develop Information

Active CompaniesMedtronic Biopharma Bv
Inactive CompaniesMedtronic Spinal And BiologicsWyeth LlcUniversity of Zurich
Active IndicationsTibial Fractures
Inactive IndicationsFractures, BoneRadius FracturesTooth Injuries +[5] 

Other Information

ATC CodeM05BC01
Related LinksKEGG